JG
PRCT icon

Joel Greenblatt’s Procept Biorobotics PRCT Stock Holding History

Joel Greenblatt’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,843
Closed -$228K – 1502
2024
Q3 		$228K Sell
2,843
-3,901
-58% -$277K ﹤0.01% 1307
2024
Q2 		$412K Buy
+6,744
New +$401K 0.01% 1137

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Joel Greenblatt's PRCT Position: Q4 2024 in Review

Joel Greenblatt sold out of Procept Biorobotics (PRCT) in Q4 2024, closing a stake of 2,843 shares — an estimated $228K sold.

Joel Greenblatt first reported a position in PRCT in Q2 2024 and held it in 2 quarters. The position peaked at $412K in Q2 2024. 281 funds tracked by Wall St. Rank hold PRCT as of Q4 2024.

  • Joel Greenblatt reported no remaining Procept Biorobotics position as of Q4 2024 after selling out during the quarter.
  • Joel Greenblatt sold 2,843 Procept Biorobotics shares in Q4 2024, an estimated $228K.
  • Joel Greenblatt first reported a position in Procept Biorobotics in Q2 2024 and held it in 2 quarters.
  • Joel Greenblatt's Procept Biorobotics position peaked at $412K in Q2 2024.
  • 281 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2024.

Based on Gotham Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.